Patient is an 18-month-old male with a history of Nasolacrimal Duct Obstruction (NLDO). He presented to the Children’s Hospital Outpatient Setting for NLD probing and stenting. After informed consent was performed, including consent for taking photos and video recordings, the patients underwent sedation without complication. The eyelids were cleaned of mucus and crusts using sterile water. The inferior puncta were dilated with a dilator. A Ritleng introducer was placed through the inferior puncta and guided along the canaliculus to a bony stop. The introducer was then rotated to coronal/vertical position and guided along the lacrimal sac through the NLD and valve of Hasner to be positioned under the inferior turbinate. Next, the introducer was removed, and the puncta was re-dilated. We used a Lacrijet 30 nasolacrimal duct stent, REF S1.1530 was opened and guided through the NLD. The inserter was removed gently, and the stent’s collarette was seated in the puncta using the disposable punctal plug inserter. The same procedure was performed on the fellow eye. Maxitrol drops were placed in the medial canthal region. The patient was awakened from sedation without complication and discharged home without complication.